The Cbl protooncoprotein has recently emerged as a component of tyrosine ki
nase-mediated signal transduction in a variety of cell types. Here, we disc
uss evidence that supports a role for Cbl as a novel negative regulator of
immune receptor signaling, and present models for its mode of function.